Smart drug reprofiling

Using a unique combination of computational chemistry, pharmacology and cheminformatics methods, Re-Pharm is successfully reprofiling marketed compounds as early stage candidates ready for partnering. To download the full article, please sign in.

Thumb repharmfinal
Nov 10, 2015
Page of
Medium repharmfinal


Re-Pharm is an early-stage drug discovery and development company based on the principles of compound re-profiling. Our goal is to identify compounds currently on the market, or previously failed to make it to market for commercial reasons, and re-purpose them to address diseases in areas of unmet medical need.

Comments are disabled